NCPDP Annual Conference: Track Sessions

Tuesday, May 7, 2024

9:30 a.m. – 10:30 a.m.
Pooja Babbrah, MBA
PBM Practice Lead
Point-of-Care Partners
Tricia Lee Rolle Pharm.D., MS, PhD
Senior Advisor, Office of the National Coordinator
U.S. Dept. of Health and Human Services
Kim Boyd
Senior Consultant and Regulatory Resource Center Lead
Point-of-Care Partners
11:00 a.m. – 12:00 p.m.
Anna Dover, Pharm.D., BCPS
Director, Product Management
FDB (First Databank, Inc.)
Julie Suko, Pharm.D.
Vice President, Editorial Content
FDB (First Databank, Inc.)
Jason Reed, Pharm.D
Senior Director, Product Management
FDB Vela
Edward D. Millikan, Pharm.D.
Senior Informatics Pharmacist
Office of Surveillance and Epidemiology (OSE), Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Jeff Deitch
Chief Executive Officer
Infowerks
Kelee Petzelt
Consultant
Point-of-Care Partners

Wednesday, May 8, 2024

11:15 a.m. – 11:45 p.m.
Mason Ingram
Director, Payer Policy
Premier Inc.

Laura D. Pone, JD
Associate, Health Care Alignment and Organization Practice
Polsinelli PC

12:00 p.m. – 12:30 p.m.
Kim Boyd
President | Principal Consultant
Boyd Consulting Group, LLC

Kristol Chism, R.Ph.
Director, Industry Relations
Optum Insight

Miranda Rochol
Senior Vice President for Provider Solutions
Prescryptive Health, Inc.

Miranda Reich , POPM
Senior Product Manager
Inovalon

Samantha Pitts, MD, MPH
Assistant Professor
Division of General Internal Medicine, Johns Hopkins Medicine

Mark Gunnels
Vice President and Principal Architect, Product Engineering
Tabula Rasa HealthCare

Candida Ruesga
Attorney
The Phoenix Law Group, PLC

Pharmacists and Pharmacy Technicians can earn Continuing Pharmacy Education (CPE) hours from the ACPE for up to 11 of the 12 concurrent educational track sessions. Complete CPE Details for NCPDP’s 2024 Annual Conference coming soon!

 

A Collaborative Approach to Fill Gaps in DTx Integration & Workflow

  • Wednesday, May 10, 2023
  • 11:15 am – 12:15 pm

DTA and NCPDP are partnering on a workshop to identify bright spots in the DTx product journey through the healthcare system and identify the existing gaps in the product journey. Stakeholders providing input include clinicians, payors, manufacturers, pricing compendia, PBMs, and more. The output, which is the focus of this discussion, is what actions are being taken or need to be taken to fill the gaps and provide sustainable models to scale patient access to digital therapeutic products.

Track Session Speakers

  • Jeff Abraham
  • Vice President, Co-Lead Digital Health Practice
  • Health Advances
  • Jessica Hauflaire
  • Chief Operating Officer
  • Digital Therapeutics Alliance
NCPDP-Elite Partner

Covermymeds logo             FDB

NCPDP’s Elite Partner Program establishes the highest level of sustained support for the valuable work of NCPDP in advancing patient safety and interoperability.

Need More Info?

We would love to hear from you. Send us a message with your comment or question and a member of our staff will contact you shortly.

       
Stay Connected